Vimarsana
Biggest News Aggregation in the World

Page 24 - Hematologic Malignancies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hematologic Malignancies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hematologic Malignancies Today - Breaking & Trending Today

Innate Pharma to Present Updated Interim Phase 2 Efficacy Results of Lacutamab in Mycosis Fungoides - Vimarsana News

Innate Pharma to Present Updated Interim Phase 2 Efficacy Results of Lacutamab in Mycosis Fungoides

Efficacy results of lacutamab in Mycosis Fungoides according to updated lymph node classification in the TELLOMAK Phase 2 study in advanced cutaneous T cell lymphomasMARSEILLE, France--(BUSINESS WIRE)--#ANKET--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that inter...

The HARMONY Alliance is set to become a research foundation - Vimarsana News

The HARMONY Alliance is set to become a research foundation

/PRNewswire/ -- The HARMONY Alliance has revolutionized the use of big data to accelerate developments in treating patients with Hematological Malignancies. A...

European Hematology Association; HARMONY Alliance: The HARMONY Alliance is set to become a research foundation - Vimarsana News

European Hematology Association; HARMONY Alliance: The HARMONY Alliance is set to become a research foundation

The HARMONY Alliance has revolutionized the use of big data in Hematologic Malignancies research.Becoming a non-profit research foundation.Bringing hematology research and patient care to the

Novel Approaches Create a Bridge to Transplant in MPNs - Vimarsana News

Novel Approaches Create a Bridge to Transplant in MPNs

Researchers may have uncovered new ways to help patients with accelerated-phase and blast-phase MPNs live longer by borrowing therapies from other blood cancers.

Live from ASCO 2023 | Ascentage Pharma Releases the First Dataset of Lisaftoclax in WM, Revealing Encouraging Therapeutic Potential - Vimarsana News

Live from ASCO 2023 | Ascentage Pharma Releases the First Dataset of Lisaftoclax in WM, Revealing Encouraging Therapeutic Potential

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and...